Literature DB >> 29858033

Prognostic impact of the integration of volumetric quantification of the solid part of the tumor on 3DCT and FDG-PET imaging in clinical stage IA adenocarcinoma of the lung.

Hideyuki Furumoto1, Yoshihisa Shimada1, Kentaro Imai1, Sachio Maehara1, Junichi Maeda1, Masaru Hagiwara1, Tetsuya Okano1, Ryuhei Masuno2, Masatoshi Kakihana1, Naohiro Kajiwara1, Tatsuo Ohira1, Norihiko Ikeda3.   

Abstract

OBJECTIVES: The aim of this study was to conduct comparative analyses of the biological malignant potential of clinical stage IA adenocarcinoma using positron emission tomography/computed tomography (PET/CT), high-resolution CT (HRCT), and three-dimensional CT (3DCT). The predictive performance of these parameters was evaluated in terms of clinical outcomes and pathological invasiveness (positive lymphatic permeation, blood-vessel invasion, pleural invasion, and lymph-node metastasis).
MATERIALS AND METHODS: We enrolled 170 patients with c-IA adenocarcinoma who underwent PET/CT, HRCT, and 3D reconstruction of lung structures using the Synapse Vincent system (Fujifilm Corporation, Tokyo, Japan) followed by complete resection. Maximum standardized uptake values (SUVmax) of F18-fluorodeoxyglucose and the size and volume of the solid part of the tumor were quantified and analyzed in relation to surgical outcomes.
RESULTS: Univariate analysis demonstrated that all the three parameters and whole-tumor volume were associated with unfavorable disease-free survival (DFS), while the volume of the solid part was the independent predictor on multivariate analysis (p < .001). The receiver operating characteristic curves for pathological invasiveness, determined using the variables dichotomized at each cut-off level (SUVmax 2.4; solid-part size 1.23 cm; solid-part volume 779 mm3), showed that all were significantly correlated with pathological invasiveness and prognosis, whereas the combination of SUVmax and the solid-part volume was the most powerful predictor of survival and pathological invasiveness compared to any other parameters: the 4-year DFS and proportion of pathological invasiveness in patients with SUVmax > 2.4 and solid-part volume > 779 mm3 versus those with SUVmax ≤ 2.4 or solid-part volume ≤779 mm3 were 81.2% versus 98.3% (p < .001) and 84.3% versus 15.1% (p < .001), respectively.
CONCLUSION: In c-IA adenocarcinoma, the volume of the solid part of the tumor was the independent predictor for unfavorable DFS, and the integration of the volume of the solid part and SUVmax was highly beneficial for the prediction of survival and pathological invasiveness.
Copyright © 2018 Elsevier B.V. All rights reserved.

Entities:  

Keywords:  Adenocarcinoma; PET/CT; Stage IA; Three-dimensional CT; Tumor volume

Mesh:

Substances:

Year:  2018        PMID: 29858033     DOI: 10.1016/j.lungcan.2018.05.001

Source DB:  PubMed          Journal:  Lung Cancer        ISSN: 0169-5002            Impact factor:   5.705


  9 in total

1.  Impact of different image reconstructions on PET quantification in non-small cell lung cancer: a comparison of adenocarcinoma and squamous cell carcinoma.

Authors:  Michael Messerli; Fotis Kotasidis; Irene A Burger; Daniela A Ferraro; Urs J Muehlematter; Corina Weyermann; David Kenkel; Gustav K von Schulthess; Philipp A Kaufmann; Martin W Huellner
Journal:  Br J Radiol       Date:  2019-02-26       Impact factor: 3.039

2.  Improving segmentation and classification of renal tumors in small sample 3D CT images using transfer learning with convolutional neural networks.

Authors:  Xi-Liang Zhu; Hong-Bin Shen; Haitao Sun; Li-Xia Duan; Ying-Ying Xu
Journal:  Int J Comput Assist Radiol Surg       Date:  2022-03-15       Impact factor: 2.924

3.  F-18 fluorodeoxyglucose uptake in lymph nodes and sonographic features on endobronchial ultrasonography predict lymph node metastasis in lung cancer patients.

Authors:  Takashi Yamamichi; Masatoshi Kakihana; Yasuyuki Nitta; Wakako Hamanaka; Naohiro Kajiwara; Tatsuo Ohira; Norihiko Ikeda
Journal:  J Thorac Dis       Date:  2020-10       Impact factor: 2.895

4.  Selecting therapy for small ground-glass tumors-the potential role of volumetric computed tomography scan.

Authors:  Xiangwen Wu; Hiran C Fernando
Journal:  J Thorac Dis       Date:  2019-05       Impact factor: 2.895

5.  Prognostic value of tumor solid-part size and solid-part volume in patients with clinical stage I non-small cell lung cancer.

Authors:  Yoshihisa Shimada; Hideyuki Furumoto; Kentaro Imai; Ryuhei Masuno; Jun Matsubayashi; Naohiro Kajiwara; Tatsuo Ohira; Norihiko Ikeda
Journal:  J Thorac Dis       Date:  2018-12       Impact factor: 2.895

6.  Postoperative recurrence of clinical early-stage non-small cell lung cancers: a comparison between solid and subsolid nodules.

Authors:  Shingo Iwano; Hiroyasu Umakoshi; Shinichiro Kamiya; Kohei Yokoi; Koji Kawaguchi; Takayuki Fukui; Shinji Naganawa
Journal:  Cancer Imaging       Date:  2019-06-07       Impact factor: 3.909

7.  Iodine-related attenuation in contrast-enhanced dual-energy computed tomography in small-sized solid-type lung cancers is associated with the postoperative prognosis.

Authors:  Shingo Iwano; Shinichiro Kamiya; Rintaro Ito; Shota Nakamura; Shinji Naganawa
Journal:  Cancer Imaging       Date:  2021-01-07       Impact factor: 3.909

8.  The utility of three-dimensional computed tomography for prediction of tumor invasiveness in clinical stage IA lung adenocarcinoma.

Authors:  Yohei Kawaguchi; Masayuki Nakao; Kenshiro Omura; Naoya Iwamoto; Hiroki Ozawa; Yasuto Kondo; Junji Ichinose; Yosuke Matsuura; Sakae Okumura; Mingyon Mun
Journal:  J Thorac Dis       Date:  2020-12       Impact factor: 2.895

9.  [Research Progress in 3D-reconstruction Based Imaging Analysis 
in Partial Solid Pulmonary Nodule].

Authors:  Zicheng Liu; He Yang; Hongya Wang; Liang Chen; Quan Zhu
Journal:  Zhongguo Fei Ai Za Zhi       Date:  2022-02-20
  9 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.